Oncology Biosimilar Market: Information By Types Of Cancer, Drug Type, Distribution Channel and Regional Outlook — Global Insights Forecast Till 2026

Apr 04, 2019   Global Statistics Representing Oncology Biosimilar Market Scenario Oncology Biosimilar is the identical copy of oncology biologics used for the treatment of cancer. These drugs are cost-effective, efficient, and have the same ability as biologics. These molecules are easy to manufacture as compared to biologics and can only be manufactured after patent expiry. According to the World Health Organization (WHO), in 2015, approximately 8.8 million people died due to cancer worldwide. Increasing pr...
Request Free Sample Report
LIST OF TABLES & FIGURES

Tables and figures

LIST OF TABLES

TABLE 1           Global Oncology Biosimilar Market Share, By Types of Cancer, 2016-2026 ($Million)

TABLE 2           Breast Cancer Occlusion Biosimilar Market Share, By Region, 2016-2026 ($ Million)

TABLE 3           Colorectal Cancer Oncology Biosimilar Market Share, By Region, 2016-2026, ($ Million)

TABLE 4           Global Oncology Biosimilar Market Share, By Drug Type, 2016-2026 ($Million)

TABLE 5           Global Oncology Biosimilar Market By Region, 2016-2026 ($ Million)

TABLE 6           Global Oncology Biosimilar Market Share Value, 2016-2026 ($Million)

TABLE 7           America Oncology Biosimilar Market Share Value, By Country, 2016-2026 ($Million)

TABLE 8           America Oncology Biosimilar Market Share value, By Types of Cancer, 2016-2026 ($Million)

TABLE 9           America Oncology Biosimilar Market Share value, By Drug Type, 2016-2026 ($Million)

TABLE 10         U.S. Oncology Biosimilar Market share, By Types of Cancer, 2016-2026 ($Million)

TABLE 11         U.S. Oncology Biosimilar Market share, By Drug Type, 2016-2026 ($Million)

TABLE 12         Canada Oncology Biosimilar Market share, By Types of Cancer, 2016-2026 ($Million)

TABLE 13         Canada Oncology Biosimilar Market share, By Drug Type, 2016-2026 ($Million)

TABLE 14         Mexico Oncology Biosimilar Market share, By Types of Cancer, 2016-2026 ($Million)

TABLE 15         Mexico Oncology Biosimilar Market share, By Drug Type, 2016-2026 ($Million)

TABLE 16         Latin America Oncology Biosimilar Market share, By Types of Cancer, 2016-2026 ($Million)

TABLE 17         Latin America Oncology Biosimilar Market share, By Drug Type, 2016-2026 ($Million)

TABLE 18         Europe Oncology Biosimilar Market share Value, By Country, 2016-2026 ($Million)

TABLE 19         Europe Oncology Biosimilar Market share, By Types of Cancer, 2016-2026 ($Million)

TABLE 20         Europe Oncology Biosimilar Market share, By Drug Type, 2016-2026 ($Million)

TABLE 21         Germany Oncology Biosimilar Market share, By Types of Cancer, 2016-2026 ($Million)

TABLE 22         Germany Oncology Biosimilar Market share, By Drug Type, 2016-2026 ($Million)

TABLE 23         France Oncology Biosimilar Market share, By Types of Cancer, 2016-2026 ($Million)

TABLE 24         France Oncology Biosimilar Market share, By Drug Type, 2016-2026 ($Million)

TABLE 25         UK Oncology Biosimilar Market share, By Types of Cancer, 2016-2026 ($Million)

TABLE 26         UK Oncology Biosimilar Market share, By Drug Type, 2016-2026 ($Million)

TABLE 27         Italy Oncology Biosimilar Market share, By Types of Cancer, 2016-2026 ($Million)

TABLE 28         Italy Oncology Biosimilar Market share, By Drug Type, 2016-2026 ($Million)

TABLE 29         Spain Oncology Biosimilar Market share, By Types of Cancer, 2016-2026 ($Million)

TABLE 30         Spain Oncology Biosimilar Market share, By Drug Type, 2016-2026 ($Million)

TABLE 31         Rest of Europe Oncology Biosimilar Market share, By Types of Cancer, 2016-2026 ($Million)

TABLE 32         Rest of Europe Oncology Biosimilar Market share, By Drug Type, 2016-2026 ($Million)

TABLE 33         Asia-Pacific Oncology Biosimilar Market share Value, By Country, 2016-2026 ($Million)

TABLE 34         Asia-Pacific Oncology Biosimilar Market share, By Types of Cancer, 2016-2026 ($Million)

TABLE 35         Asia-Pacific Oncology Biosimilar Market share, By Drug Type, 2016-2026 ($Million)

TABLE 36         Japan Oncology Biosimilar Market share, By Types of Cancer, 2016-2026 ($Million)

TABLE 37         Japan Oncology Biosimilar Market share, By Drug Type, 2016-2026 ($Million)

TABLE 38         China Oncology Biosimilar Market share, By Types of Cancer, 2016-2026 ($Million)

TABLE 39         China Oncology Biosimilar Market share, By Drug Type, 2016-2026 ($Million)

TABLE 40         Australia Oncology Biosimilar Market share, By Types of Cancer, 2016-2026 ($Million)

TABLE 41         Australia Oncology Biosimilar Market share, By Drug Type, 2016-2026 ($Million)

TABLE 42         India Oncology Biosimilar Market share, By Types of Cancer, 2016-2026 ($Million)

TABLE 43         India Oncology Biosimilar Market share, By Drug Type, 2016-2026 ($Million)

TABLE 44         South Korea Oncology Biosimilar Market share, By Types of Cancer, 2016-2026 ($Million)

TABLE 45         South Korea Oncology Biosimilar Market share, By Drug Type, 2016-2026 ($Million)

TABLE 46         Rest of Asia-pacific Oncology Biosimilar Market share, By Types of Cancer, 2016-2026 ($Million)

TABLE 47         Rest of Asia-pacific Oncology Biosimilar Market share, By Drug Type, 2016-2026 ($Million)

TABLE 48         LAMEA Oncology Biosimilar Market share Value, By Country, 2016-2026 ($Million)

TABLE 49         LAMEA Oncology Biosimilar Market share, By Types of Cancer, 2016-2026 ($Million)

TABLE 50         LAMEA Oncology Biosimilar Market share, By Drug Type, 2016-2026 ($Million)

TABLE 51         Saudi Arabia Oncology Biosimilar Market share, By Types of Cancer, 2016-2026 ($Million)

TABLE 52         Saudi Arabia Oncology Biosimilar Market share, By Drug Type, 2016-2026 ($Million)

TABLE 53         South Africa Oncology Biosimilar Market share, By Drug Type, 2016-2026 ($Million)

TABLE 54         South Africa Oncology Biosimilar Market share, By Drug Type, 2016-2026 ($Million)

TABLE 55         Brazil Oncology Biosimilar Market share, By Types of Cancer, 2016-2026 ($Million)

TABLE 56         Brazil Oncology Biosimilar Market share, By Drug Type, 2016-2026 ($Million)

TABLE 57         Rest of LAMEA Oncology Biosimilar Market share, By Types of Cancer, 2016-2026 ($Million)

TABLE 58         Rest of LAMEA Oncology Biosimilar Market share, By Drug Type, 2016-2026 ($Million)    

LIST OF FIGURES

FIGURE 1         Global Oncology Biosimilar Market Overview

FIGURE 2         Value Chain Analysis

FIGURE 3         Bargaining Power of Suppliers

FIGURE 4         Bargaining Power of Buyers

FIGURE 5         Threat of Substitutes

FIGURE 6         Threat of New Entrants

FIGURE 7         Competitive Rivalry

FIGURE 8         Oncology Biosimilar Market, Market Share Analysis, 2018

FIGURE 9         Global Oncology Biosimilar Market, 2016-2026

FIGURE 10       U.S. Oncology Biosimilar Market share, 2016-2026 ($Million)

FIGURE 11       Canada Oncology Biosimilar Market share, 2016-2026 ($Million)

FIGURE 12       Mexico Oncology Biosimilar Market share, 2016-2026 ($Million)

FIGURE 13       Germany Oncology Biosimilar Market share, 2016-2026 ($Million)

FIGURE 14       France Oncology Biosimilar Market share, 2016-2026 ($Million)

FIGURE 15       UK Oncology Biosimilar Market share, 2016-2026 ($Million)

FIGURE 16       Italy Oncology Biosimilar Market share, 2016-2026 ($Million)

FIGURE 17       Spain Oncology Biosimilar Market share, 2016-2026 ($Million)

FIGURE 18       Rest of Europe Oncology Biosimilar Market share, 2016-2026 ($Million)

FIGURE 19       Japan Oncology Biosimilar Market share, 2016-2026 ($Million)

FIGURE 20       China Oncology Biosimilar Market share, 2016-2026 ($Million)

FIGURE 21       Australia Oncology Biosimilar Market share, 2016-2026 ($Million)

FIGURE 22       India Oncology Biosimilar Market share, 2016-2026 ($Million)

FIGURE 23       South Korea Oncology Biosimilar Market share, 2016-2026 ($Million)

FIGURE 24       Rest of Asia-pacific Oncology Biosimilar Market share, 2016-2026 ($Million)

FIGURE 25       Saudi Arabia Oncology Biosimilar Market share, 2016-2026 ($Million)

FIGURE 26       South Africa Oncology Biosimilar Market share, 2016-2026 ($Million)

FIGURE 27       Brazil Oncology Biosimilar Market share, 2016-2026 ($Million)

FIGURE 28       Rest of LAMEA Oncology Biosimilar Market share, 2016-2026 ($Million)

FIGURE 29       Teva Pharmaceutical Industries Ltd.: Revenue Analysis, ($ million)

FIGURE 30       Teva Pharmaceutical Industries Ltd.: Segment Revenue 2017 (%)